ORAMED PHARMACEUTICALS INC. — All Filings
911 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10-QT
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B5
424B7
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
EFFECT
FWP
NT 10-K
NT 10-Q
NTN 10Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-3
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | ANNUAL REPORT | 0001213900-26-034835 | Mar 26, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-031015 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | — | 0001213900-26-031011 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | — | 0001213900-26-031013 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | — | 0001213900-26-031012 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | — | 0001213900-26-028291 | Mar 16, 2026 | Mar 12, 2026 |
| 8-K | 8-K | 0001012975-26-000195 | Feb 20, 2026 | Feb 19, 2026 |
| SCHEDULE 13D/A | — | 0001213900-26-018576 | Feb 19, 2026 | — |
| SCHEDULE 13G/A | — | 0001012975-26-000138 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001373604-26-000012 | Feb 9, 2026 | — |
| 4 | — | 0001213900-26-009477 | Jan 29, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-009476 | Jan 29, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-009478 | Jan 29, 2026 | Jan 22, 2026 |
| SCHEDULE 13D | — | 0001213900-26-009570 | Jan 29, 2026 | — |
| 4 | — | 0001213900-26-009479 | Jan 29, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-006215 | Jan 21, 2026 | Jan 14, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-004382 | Jan 14, 2026 | Jan 12, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-001983 | Jan 7, 2026 | — |
| 4 | — | 0001213900-26-001278 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-001279 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-001280 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-001282 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-001275 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-001277 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-000658 | Jan 2, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-000661 | Jan 2, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001012975-25-000992 | Dec 31, 2025 | Dec 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-127133 | Dec 31, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-111298 | Nov 17, 2025 | Nov 16, 2025 |
| 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-111299 | Nov 17, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-111310 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001012975-25-000769 | Nov 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-109980 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-101825 | Oct 24, 2025 | Oct 20, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-096322 | Oct 6, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | — | 0001213900-25-081720 | Aug 28, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-079361 | Aug 21, 2025 | Aug 19, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-079364 | Aug 21, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-076668 | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-076929 | Aug 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-066819 | Jul 23, 2025 | Jul 22, 2025 |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-25-064678 | Jul 16, 2025 | Dec 31, 2024 |
| DEF 14A | PROXY STATEMENT | 0001213900-25-064755 | Jul 16, 2025 | Aug 19, 2025 |
| ARS | FORM ARS | 0001213900-25-064758 | Jul 16, 2025 | Dec 31, 2024 |
| 4 | — | 0001213900-25-052622 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052620 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052618 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052623 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001213900-25-052624 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-046436 | May 21, 2025 | — |